Depression Center Leadership
The Depression Center Leadership (DCL) team establishes priorities and strategic direction for the Center, advises on organizational, operational, programmatic, and development goals, and guides the initiation and achievement of integrative University of Michigan and extramural collaborative relationships. The DCL advances the Depression Center’s interests and development by promoting and fostering the coordination and integration of activities with the Department of Psychiatry, in addition to other Health System and campus disciplines and advisory authorities across the institution.
|John Greden, M.D., Founder and Executive Director
Rachel Upjohn Professor of Psychiatry and Clinical Neurosciences
Research Professor, Molecular & Behavioral Neuroscience Institute
Founder and Chair, National Network of Depression Centers
Dr. John F. Greden is the Rachel Upjohn Professor of Psychiatry and Clinical Neurosciences in the Department of Psychiatry, Founder and Executive Director of the University of Michigan Depression Center, Founding Chair, National Network of Depression Centers (NNDC), and Research Professor in the Molecular and Behavioral Neuroscience Institute. He joined the faculty at the University of Michigan Medical School in 1974 and served as Chair of Michigan’s Department of Psychiatry from 1985 to 2007 when he stepped down to focus on directing the Depression Center and developing the NNDC.
Dr. Greden earned his B.S. and M.D. at the University of Minnesota, completed his internship at Harbor/UCLA, and his psychiatry residency at the University of Minnesota Hospitals and Walter Reed Army Medical Center in Washington, DC. He has authored or co-authored more than 400 articles, refereed abstracts, books, book chapters, and presented approximately 335 invited lectures. He has almost three decades of NIH funding as investigator, co-investigator and consultant. Major research themes have focused upon studying biomarkers and developing treatment strategies to prevent recurrences of depression and bipolar disorders. He has served as mentor for more than a dozen NIH or Veterans Administration “K” awardees and young investigators, and presented 10 keynote addresses for the American Psychiatric Association’s “Psychiatry Young Investigators’ Colloquium.”
To address the huge health burdens, disabilities and costs associated with clinical depressions, bipolar disorders, and related conditions, Dr. Greden proposed establishment of the country’s inaugural comprehensive Depression Center at the University of Michigan. Approved by the Regents in 2001, a new Depression Center-Ambulatory Psychiatry facility opened in 2006. The Center integrates research, clinical, educational and public policy efforts of more than 300 members from 13 University Schools and Colleges and 33 different University departments. Dr. Greden subsequently led efforts to establish similar centers throughout the country and integrate them into a National Network of Depression Centers patterned after the National Cancer Center Network. 16 eminent universities signed an NNDC Charter in a ceremony in Ann Arbor in October, 2008 and the NNDC has now grown to 21. Dr. Greden served as the Chair of the National Network of Depression Centers.
Dr. Greden is past-President of the Society of Biological Psychiatry; the Psychiatric Research Society; the American Association of Chairs of Departments of Psychiatry (AACDP); the Academic Psychiatry Consortium; and the Board of Directors of the American Foundation for Suicide Prevention . He edited the Journal of Psychiatric Research for seven years, chaired the Council on Research for the American Psychiatric Association for five years, served as Council Member of the American College of Neuropsychopharmacology (ACNP), Co-Chair of the National Psychiatry Training Council established by NIMH, and was selected as the 2005 recipient of the Distinguished Alumnus Award of the University of Minnesota Medical School. In 2013 the University of Michigan’s Council for Disability Concerns awarded Dr. Greden the James T. Neubacher Award.
|Gregory Dalack, M.D.
Associate Professor of Psychiatry
Chair of Psychiatry
Gregory W. Dalack is the Chair of the Department of Psychiatry. He came to the University of Michigan in 1992 where he initially was Chief of the Mental Health Clinic at the VA Ann Arbor Healthcare System (VAAAHS). From 1999-2005, he was Chief of the Psychiatry Service at VAAAHS. In 2005, he became Associate Chair for Education and Academic Affairs (a position he still holds) for the department. From 2006-2007, he was Vice Chair of the department until assuming the role of Interim Chair in 2007.
Dr. Dalack has had research interests in the treatment of chronic and persistent mental illnesses, particularly focusing on schizophrenia. He has conducted studies examining nicotine addiction and smoking cessation interventions in schizophrenia, health behaviors in schizophrenia, and metabolic effects of second-generation antipsychotic medications in schizophrenia.
Dr. Dalack received his medical degree from the College of Physicians and Surgeons of Columbia University, completed his internship in Medicine at the Presbyterian Hospital in the City of New York and his Psychiatry Residency at the New York State Psychiatric Institute (NYSPI). Also at Columbia and NYSPI, he completed a fellowship in Psychopharmacology.
|Nancy Davis, B.A.
Associate Director, Neuroscience
Office of Development
|Patricia Deldin, Ph.D., Associate Director
Professor of Psychology, College of Literature, Science & the Arts
Professor of Psychiatry
Patricia Deldin is a professor of Psychology and an associate professor of Psychiatry at the University of Michigan. Following a two year research position at the National Institute of Mental Health (NIMH), Dr. Deldin received her Ph.D. from the University of Illinois, with a major in clinical psychology and a minor in biological psychology. She then completed an internship at the University of Wisconsin, Madison, Department of Psychiatry. Dr. Deldin was on the faculty of Harvard University (1995-2003) before coming to the University of Michigan in 2003.
Dr. Deldin is one of the associate directors of the Depression center and serves on the board of directors of the Society for Research in Psychopathology.
Her primary research program is comprised of information processing studies designed to distinguish memory, attention, and expectancy dysfunction in major depressives, dysthymics and controls. ERP, fMRI and behavioral studies provide complementary portraits of cognitive and emotional processing associated with depression.
|Rosalind Garcia-Tosi, Sc.D, M.PH., M.S.W.
Associate Director of Administration
Rosalind Garcia-Tosi joined the Depression Center in November 2013 as the Associate Director of Administration. Dr. Garcia-Tosi earned her Doctor of Science in Health Systems Management from Tulane University’s School of Public Health and Tropical Medicine and holds a MPH in Health Management and Policy and a MSW in Administration from the University of Michigan. She has extensive expertise in mental health, program evaluation, maternal and child health, management, strategic planning, collaboration, health equity, and health disparities.
Prior to joining the Depression Center, Dr. Garcia-Tosi held various positions at Mott Children’s Health Center, including Director of Child and Adolescent Psychiatry, Director of Strategic Planning and Evaluation, Chair of the Institutional Review Board, and a member of the Center’s Management Team. She has also worked for a public health policy research organization evaluating maternal and child health programs.
|Anne Harrington, Ph.D.
Since coming to the Ross School of Business at the University of Michigan in 1988 as a member of the Communication Faculty, Anne White Harrington has taught a variety of oral and written communication courses. She has participated in numerous special programs and events, including Global MBA, Executive MBA, Tauber Manufacturing Institute, and Erasmus Exchange programs. She is a founding faculty member and a Course Coordinator of the flagship MBA course, Multidisciplinary Action Projects (MAP), and has been the action learning project director for several Executive Education programs. In her role as Director of Instructional Development she supervises the PhD Teacher Development Program, offers Methods of Teaching courses, and provides workshops and coaching for faculty and doctoral students.
Professor Harrington received the Victor L. Bernard Faculty Leadership in Teaching Award in 1998 and the Ph.D. Award for Teaching Excellence in 2000. She earned a Master of Arts in Teaching from Northwestern University, a Master in Communication Arts from Michigan State University, and a Ph.D. in Communication from the University of Michigan.
Melvin McInnis, M.D., Associate Director
Melvin G. McInnis, M.D., the Thomas B. and Nancy Upjohn Woodworth Professor of Bipolar Disorder and Depression, leads the University of Michigan’s clinical treatment and research group for Bipolar Disorder. Dr. McInnis, received his medical training at the University of Iceland, where he developed his interest in the genetics of bipolar disorder. He completed a psychiatric residency at the Bethlem Royal and Maudsley Hospitals at the University of London and then spent 15 years at Johns Hopkins University, where he became an associate professor and director of the George Brown Genetics Laboratory. Dr. McInnis has published more than 100 peer-reviewed articles on the genetics and clinical course of bipolar disorders. He is known as an expert in the diagnosis, genetics and clinical management of bipolar and depressive disorders in adolescents and adults.
|Michelle Riba, M.D., M.S., Associate Director
Professor, Department of Psychiatry
Associate Chair for Integrated Medical and Psychiatric Services, Department of Psychiatry
Zonal Representative (Area 2, USA), World Psychiatric Association
Past President, American Psychiatric Association
Dr. Riba is Clinical Professor and Associate Chair for Integrated Medical and Psychiatric Services in the Department of Psychiatry, Associate Director of the University of Michigan Comprehensive Depression Center, and Director of the PsychOncology Program at the University of Michigan Comprehensive Cancer Center.
Dr. Riba’s clinical and research interests as a psychosomatic medicine psychiatrist include primary care psychiatry, depression and cardiovascular disease, depression and cancer, and the role of screening for distress in patients with cancer/medical illness. Dr. Riba is a Zonal Representative for the World Psychiatric Association and Past-President of the American Psychiatric Association, the Association for Academic Psychiatry, and the American Association of Directors of Psychiatric Residency Training.
As director of the University of Michigan Comprehensive Cancer Center PsychOncology Program, Dr. Riba leads a multidisciplinary group of clinicians who care for the emotional needs of cancer patients and their families; including physicians, nurses, social workers, art therapists, child life specialists and psychologists. Through numerous scientific papers, APA courses, books, and presentations at scientific meetings, she continues to advance the dialogue and research in this important clinical area nationally and internationally.
Dr. Riba is the author or editor of over 100 scientific articles, books, chapters and scientific abstracts. She has served on the editorial board of Psychiatric Services and Cancer News on the Net, Current Psychiatry and has served on the editorial advisory board of the American Psychiatric Press, Inc. She is a reviewer for Psycho-Oncology; Academic Psychiatry; Psychiatric Services; Journal of Psychiatric Practice; and Psychosomatic Medicine; Breast Cancer Research and Treatment. She has co-edited 15 editions of The American Psychiatric Press Review of Psychiatry series. She has co-edited Psychopharmacology and Psychotherapy: A Collaborative Approach; Primary Care Psychiatry; and The Doctor-Patient Relationship in Pharmacotherapy: Improving Treatment Effectiveness and has edited or co-written another 15 books.